文献
J-GLOBAL ID:202202259060192180
整理番号:22A0497649
レニン-アンギオテンシン系を標的とする薬剤使用者における腎臓癌予後の改善【JST・京大機械翻訳】
Improved renal cancer prognosis among users of drugs targeting renin-angiotensin system
著者 (9件):
Eskelinen Tommi
(Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland)
,
Veitonmaeki Thea
(Department of Urology, TAYS Cancer Center, Tampere, Finland)
,
Kotsar Andres
(Department of Urology, Tartu University Hospital, Tartu, Estonia)
,
Tammela Teuvo L. J.
(Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland)
,
Tammela Teuvo L. J.
(Department of Urology, TAYS Cancer Center, Tampere, Finland)
,
Poyhonen Antti
(Centre for Military Medicine, The Finnish Defence Forces, Helsinki, Finland)
,
Murtola Teemu J.
(Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland)
,
Murtola Teemu J.
(Department of Urology, TAYS Cancer Center, Tampere, Finland)
,
Murtola Teemu J.
(Department of Urology, Tartu University Hospital, Tartu, Estonia)
資料名:
Cancer Causes & Control
(Cancer Causes & Control)
巻:
33
号:
2
ページ:
313-320
発行年:
2022年
JST資料番号:
W4133A
ISSN:
0957-5243
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)